Kelsey Moody, CEO of Ichor Therapeutics, discusses the creation of a gut-stable antibody mimetic for Parkinson’s disease and announces 10 million dollars in investment from Juvenescence into Ichor portfolio company Antoxerene Inc. at the Ending Age-Related Diseases conference in NYC.
More at: https://www.leafscience.org/ending-age-related-diseases-2018/
Read more
Comments are closed.